We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
+0.73%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$24.1B
AUM Growth
+$1.97B
Cap. Flow
+$2.05B
Cap. Flow %
8.49%
Top 10 Hldgs %
10.49%
Holding
3,709
New
1,118
Increased
953
Reduced
622
Closed
747

Sector Composition

Rank Sector Weight
1 Healthcare 20.28%
2 Financials 16.56%
3 Technology 13.74%
4 Consumer Discretionary 11.01%
5 Communication Services 4.83%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
APSG.WS
851
CALL
DELISTED
Apollo Strategic Growth Capital Warrants, each exercisable for one Class A Ordinary Share at an exer
APSG.WS
$5.86M 0.02%
599,997
+100,000
+20% +$103K
BNZI icon
852
Banzai International
BNZI
$7.29M
$5.84M 0.02%
+60
New +$5.82M
CCV
853
DELISTED
Churchill Capital Corp V
CCV
$5.84M 0.02%
597,262
+397,282
+199% +$3.91M
FRG
854
DELISTED
Franchise Group, Inc.
FRG
$5.84M 0.02%
164,839
+74,328
+82% +$2.59M
XOM icon
855
CALL
ExxonMobil
XOM
$651B
$5.83M 0.02%
+99,200
New +$5.65M
BGSX
856
DELISTED
Build Acquisition Corp.
BGSX
$5.81M 0.02%
599,988
INAQU
857
DELISTED
Insight Acquisition Corp. Units
INAQU
$5.79M 0.02%
+582,164
New +$5.76M
TE
858
T1 Energy
TE
$1.4B
$5.78M 0.02%
+585,636
New +$5.4M
DELL icon
859
Dell
DELL
$283B
$5.73M 0.02%
108,665
-109,073
-50% -$5.44M
RUM icon
860
RUM Group Inc
RUM
$1.57B
$5.72M 0.02%
588,684
PEAR
861
DELISTED
Pear Therapeutics, Inc. Class A Common Stock
PEAR
$5.71M 0.02%
574,050
+23,862
+4% +$236K
GGPIW
862
CALL
DELISTED
Gores Guggenheim, Inc. Warrant
GGPIW
$5.69M 0.02%
556,905
+156,909
+39% +$308K
DINO icon
863
HF Sinclair
DINO
$15.9B
$5.69M 0.02%
171,749
-271,816
-61% -$8.26M
OXM icon
864
Oxford Industries
OXM
$577M
$5.68M 0.02%
62,939
+11,550
+22% +$1.05M
OMCL icon
865
Omnicell
OMCL
$1.86B
$5.65M 0.02%
38,075
+27,883
+274% +$4.27M
HURN icon
866
Huron Consulting
HURN
$1.82B
$5.64M 0.02%
+108,449
New +$5.28M
XLF icon
867
CALL
State Street Financial Select Sector SPDR ETF
XLF
$56.1B
$5.63M 0.02%
150,100
-40,500
-21% -$1.52M
LPSN icon
868
LivePerson
LPSN
$18.9M
$5.63M 0.02%
6,369
+3,245
+104% +$3.06M
CHT icon
869
Chunghwa Telecom
CHT
$33.2B
$5.61M 0.02%
142,861
+21,107
+17% +$863K
HERAW
870
CALL
DELISTED
FTAC Hera Acquisition Corp. Warrant
HERAW
$5.61M 0.02%
575,994
TXN icon
871
Texas Instruments
TXN
$255B
$5.61M 0.02%
29,172
+15,436
+112% +$2.94M
CTAQ
872
DELISTED
Carney Technology Acquisition Corp. II Class A Common Stock
CTAQ
$5.6M 0.02%
+573,072
New +$5.57M
CQP icon
873
Cheniere Energy
CQP
$31.8B
$5.59M 0.02%
137,580
+65,662
+91% +$2.74M
QNCX icon
874
Quince Therapeutics
QNCX
$17.5M
$5.56M 0.02%
304
+111
+58% +$1.77M
XLF icon
875
State Street Financial Select Sector SPDR ETF
XLF
$56.1B
$5.54M 0.02%
147,657
+24,347
+20% +$911K

Similar funds

Marshall Wace's Q3 2021 Portfolio in Review

As of Q3 2021, Marshall Wace held 3,709 positions worth $24.1B, up 8.9% from $22.1B the previous quarter. Its ten largest holdings account for 10% of the portfolio.

Marshall Wace deployed $2.05B of net new capital in Q3 2021, opening 1,118 new positions and adding to 953 existing holdings. Its largest new stake was SkinHealth Systems: 4,113,430 shares worth $107M.

By sector, the portfolio is most concentrated in Healthcare at 20% of assets, down from 21% a quarter earlier, followed by Financials and Technology.

On the sell side, the largest reduction was Biogen, an estimated $210M trimmed.

  • Marshall Wace's largest Q3 2021 buy was SkinHealth Systems: 4,113,430 shares worth $107M.
  • Marshall Wace added most to Uber in Q3 2021, an estimated $127M increase.
  • Marshall Wace's biggest Q3 2021 reduction was Biogen, cutting an estimated $210M.
  • Marshall Wace fully exited Vipshop in Q3 2021, selling an estimated $58.7M.
  • Marshall Wace's ten largest holdings make up 10% of its $24.1B portfolio in Q3 2021.
  • Marshall Wace opened 1,118 new positions and closed 747 in Q3 2021.
  • Marshall Wace's portfolio value rose 8.9% quarter-over-quarter to $24.1B.

Based on Marshall Wace's 13F filing for Q3 2021, filed 15 Nov 2021.